1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Generics: Global Group of Eight (G8) Industry Guide

Generics: Global Group of Eight (G8) Industry Guide

  • January 2016
  • -
  • MarketLine
  • -
  • 163 pages

Summary

Table of Contents

Search Inside

Introduction

The G8 Generics industry guide provides top-line qualitative and quantitative summary information including: market size (value and volume 2011-15, and forecast to 2020). The guide also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Features and benefits

* Save time carrying out entry-level research by identifying the size, growth, and leading players in the G8 generics market
* Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the G8 generics market
* Leading company profiles reveal details of key generics market players’ G8 operations and financial performance
* Add weight to presentations and pitches by understanding the future growth prospects of the G8 generics market with five year forecasts
* Compares data from the US, Canada, Germany, France, UK, Italy, Russia and Japan, alongside individual chapters on each country

Highlights

The G8 countries contributed $142.9 billion in 2015 to the global generics industry, with a compound annual growth rate (CAGR) of 6% between 2011 and 2015. The G8 countries are expected to reach a value of $188.6 billion in 2020, with a CAGR of 5.7% over the 2015-20 period.
Among the G8 nations, the US is the leading country in the generics industry, with market revenues of $94.0 billion in 2015. This was followed by Japan and Russia, with a value of $10.2 and $10.0 billion, respectively.
The US is expected to lead the generics industry in the G8 nations with a value of $128.0 billion in 2016, followed by Russia and Japan with expected values of $15.9 and $11.9 billion, respectively.

Your key questions answered

* What was the size of the G8 generics market by value in 2015?
* What will be the size of the G8 generics market in 2020?
* What factors are affecting the strength of competition in the G8 generics market?
* How has the market performed over the last five years?
* How large is the G8 generics market in relation to its regional counterparts?

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
Get This Report
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • January 2017
  • by GlobalData

PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Global Drug Forecast and Market Analysis to 2025 Summary Systemic Lupus Erythematosus (SLE) is a systemic inflammatory autoimmune disease ...

PharmaPoint: Ulcerative Colitis - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Ulcerative Colitis - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • January 2017
  • by GlobalData

PharmaPoint: Ulcerative Colitis - Global Drug Forecast and Market Analysis to 2025 Summary Ulcerative Colitis (UC) is a type of chronic IBD that causes inflammation and ulcers in the innermost lining of ...

PharmaFocus: Tauopathies - Global Market Analysis

PharmaFocus: Tauopathies - Global Market Analysis

  • $ 9495
  • Industry report
  • February 2017
  • by GlobalData

PharmaFocus: Tauopathies - Global Market Analysis Summary Tauopathies are a class of more than 20 neurodegenerative diseases characterized by tau protein aggregation in the brain. There are currently no ...


ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.